Citadel Advisors
CLOV icon

Citadel Advisors’s Clover Health Investments CLOV Stock Holding History

Citadel Advisors’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.31M Buy
1,878,048
+730,108
+64% +$1.58M ﹤0.01% 5074
2025
Q4 		$2.7M Sell
1,147,940
-339,710
-23% -$929K ﹤0.01% 5366
2025
Q3 		$4.55M Sell
1,487,650
-2,042,721
-58% -$5.83M ﹤0.01% 4532
2025
Q2 		$9.85M Buy
3,530,371
+1,796,356
+104% +$5.91M ﹤0.01% 3042
2025
Q1 		$6.23M Buy
1,734,015
+822,712
+90% +$3.3M ﹤0.01% 3540
2024
Q4 		$2.87M Buy
911,303
+767,454
+534% +$2.74M ﹤0.01% 4913
2024
Q3 		$406K Sell
143,849
-1,509,955
-91% -$3.46M ﹤0.01% 8700
2024
Q2 		$2.03M Buy
1,653,804
+1,620,062
+4,801% +$1.45M ﹤0.01% 5270
2024
Q1 		$26.8K Sell
33,742
-100,182
-75% -$91.2K ﹤0.01% 12791
2023
Q4 		$128K Sell
133,924
-3,388,453
-96% -$3.33M ﹤0.01% 10625
2023
Q3 		$3.8M Sell
3,522,377
-1,825,896
-34% -$2.17M ﹤0.01% 4092
2023
Q2 		$4.8M Buy
5,348,273
+3,476,461
+186% +$3.08M ﹤0.01% 3715
2023
Q1 		$1.58M Sell
1,871,812
-57,055
-3% -$62.5K ﹤0.01% 5813
2022
Q4 		$1.79M Buy
1,928,867
+1,320,658
+217% +$1.76M ﹤0.01% 5683
2022
Q3 		$1.03M Sell
608,209
-706,891
-54% -$1.85M ﹤0.01% 6912
2022
Q2 		$2.81M Sell
1,315,100
-627,379
-32% -$1.67M ﹤0.01% 4874
2022
Q1 		$6.9M Sell
1,942,479
-1,646,667
-46% -$4.77M ﹤0.01% 3576
2021
Q4 		$13.4M Buy
3,589,146
+3,080,693
+606% +$18.9M ﹤0.01% 2589
2021
Q3 		$3.76M Sell
508,453
-438,258
-46% -$3.75M ﹤0.01% 4879
2021
Q2 		$12.6M Buy
946,711
+432,936
+84% +$4.25M ﹤0.01% 2732
2021
Q1 		$3.88M Sell
513,775
-162,546
-24% -$1.83M ﹤0.01% 4831
2020
Q4 		$11.3M Buy
+676,321
New +$7.53M ﹤0.01% 2474

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors's CLOV Position: Q1 2026 in Review

Citadel Advisors increased its Clover Health Investments (CLOV) stake by 64% in Q1 2026, buying an estimated $1.58M and bringing the position to 1,878,048 shares worth $3.31M. The position accounts for ﹤0.01% of the portfolio, ranked #5074.

Citadel Advisors first reported a position in CLOV in Q4 2020 and has held it in 22 quarters since. The position peaked at $13.4M in Q4 2021. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Citadel Advisors held 1,878,048 shares of Clover Health Investments worth $3.31M as of Q1 2026.
  • Citadel Advisors bought 730,108 Clover Health Investments shares in Q1 2026, an estimated $1.58M.
  • Clover Health Investments made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5074 holding.
  • Citadel Advisors first reported a position in Clover Health Investments in Q4 2020 and has held it in 22 quarters since.
  • Citadel Advisors's Clover Health Investments position peaked at $13.4M in Q4 2021.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.